Kidney Epidemiology and Cost Center, University of Michigan, Ann Arbor, MI; Department of Surgery, University of Michigan, Ann Arbor, MI.
Arbor Research Collaborative for Health, Ann Arbor, MI.
Am J Kidney Dis. 2021 Sep;78(3):369-379.e1. doi: 10.1053/j.ajkd.2021.01.019. Epub 2021 Apr 20.
RATIONALE & OBJECTIVE: As the proportion of arteriovenous fistulas (AVFs) compared with arteriovenous grafts (AVGs) in the United States has increased, there has been a concurrent increase in interventions. We explored AVF and AVG maturation and maintenance procedural burden in the first year of hemodialysis.
Observational cohort study.
SETTING & PARTICIPANTS: Patients initiating hemodialysis from July 1, 2012, to December 31, 2014, and having a first-time AVF or AVG placement between dialysis initiation and 1 year (N = 73,027), identified using the US Renal Data System (USRDS).
Patient characteristics.
Successful AVF/AVG use and intervention procedure burden.
For each group, we analyzed interventional procedure rates during maturation maintenance phases using Poisson regression. We used proportional rate modeling for covariate-adjusted analysis of interventional procedure rates during the maintenance phase.
During the maturation phase, 13,989 of 57,275 patients (24.4%) in the AVF group required intervention, with therapeutic interventional requirements of 0.36 per person. In the AVG group 2,904 of 15,572 patients (18.4%) required intervention during maturation, with therapeutic interventional requirements of 0.28 per person. During the maintenance phase, in the AVF group 12,732 of 32,115 patients (39.6%) required intervention, with a therapeutic intervention rate of 0.93 per person-year. During maintenance phase, in the AVG group 5,928 of 10,271 patients (57.7%) required intervention, with a therapeutic intervention rate of 1.87 per person-year. For both phases, the intervention rates for AVF tended to be higher on the East Coast while those for AVG were more uniform geographically.
This study relies on administrative data, with monthly recording of access use.
During maturation, interventions for both AVFs and AVGs were relatively common. Once successfully matured, AVFs had lower maintenance interventional requirements. During the maturation and maintenance phases, there were geographic variations in AVF intervention rates that warrant additional study.
在美国,动静脉瘘(AVF)与动静脉移植物(AVG)的比例增加,相应的干预治疗也有所增加。本研究旨在探讨血液透析第一年动静脉瘘和动静脉移植物的成熟和维持过程中的操作负担。
观察性队列研究。
2012 年 7 月 1 日至 2014 年 12 月 31 日期间开始血液透析的患者,且在透析开始至 1 年内(N=73027)首次进行动静脉瘘或动静脉移植物置管,通过美国肾脏数据系统(USRDS)确定。
患者特征。
动静脉瘘/动静脉移植物的使用情况和干预操作负担。
对于每组,我们使用泊松回归分析成熟维持阶段的干预程序率。我们使用比例率模型对维持阶段的干预程序率进行协变量调整分析。
在动静脉瘘组中,57275 例患者中有 13989 例(24.4%)在成熟阶段需要干预,每人需要 0.36 次治疗性介入。在动静脉移植物组 2 中,15572 例患者中有 2904 例(18.4%)在成熟阶段需要干预,每人需要 0.28 次治疗性介入。在维持阶段,32115 例患者中有 12732 例(39.6%)在动静脉瘘组需要干预,每人每年的治疗性干预率为 0.93。在维持阶段,10271 例患者中有 5928 例(57.7%)在动静脉移植物组需要干预,每人每年的治疗性干预率为 1.87。在两个阶段,动静脉瘘的干预率在东海岸较高,而动静脉移植物的干预率则更均匀。
本研究依赖于管理数据,每月记录通路使用情况。
在成熟阶段,动静脉瘘和动静脉移植物的干预都比较常见。一旦成熟,动静脉瘘的维持性干预需求较低。在成熟和维持阶段,动静脉瘘的干预率存在地域差异,需要进一步研究。